Determination of the ED95 of intranasal sufentanil combined with intranasal dexmedetomidine for moderate sedation during endoscopic ultrasonography

doi:10.12998/wjcc.v10.i9.2773

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3407)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

272

WORD

153

HTML

1542

Figures (1-3)

220

Tables (1-5)

223

Sum=2410

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

291

Download

706

Sum=997

Mar 26, 2022 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Cases. Mar 26, 2022; 10(9): 2773-2782
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2773

Full Size Figure Download Figure

Figure 1 Schematic representation of patients’ flow and the continual reassessment method applied in this applied in this clinical trial.

Citation: Zou Y, Li N, Shao LJZ, Liu FK, Xue FS, Tao X. Determination of the ED₉₅of intranasal sufentanil combined with intranasal dexmedetomidine for moderate sedation during endoscopic ultrasonography. World J Clin Cases 2022; 10(9): 2773-2782
URL: https://www.wjgnet.com/2307-8960/full/v10/i9/2773.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i9.2773